arrow
A

Ane Appelt

copenhagen university hospital - rigshospitalet
H指数:31
被引数:4,923

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

How to plan and deliver lung cancer reirradiation: A consensus approach from the ESTRO reirradiation and lung focus groups and ReCOG

如何规划和实施肺癌再程放疗:ESTRO再程放疗与肺癌重点小组及ReCOG的共识方法

2026-10-210
OA
Planned versus accumulated dose in radiotherapy of oropharyngeal carcinoma – Do recurrences occur in unintended cold spots?

口咽癌放射治疗中的计划剂量与累积剂量——复发是否发生在非预期的冷点区域?

2026-10-210
PRE
Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial

微波消融与立体定向体部放射治疗用于寡转移性结直肠癌肝转移(LAVA-CRLM):一项前瞻性、随机化、Ⅱ期试验

2026-09-250
OA
Clinical oncologist and NHS commissioner perspectives on reirradiation for recurrent cancer

临床肿瘤学家和NHS commissioners对复发癌再放疗的观点

2026-05-280
OAAI
Patient perspectives on reirradiation for recurrent cancer, to inform future clinical trial design

复发癌再照射患者的观点,以指导未来临床试验设计

2026-05-280
OAAI
Multicenter study of dose accumulation for reirradiation: Intercenter variation in radiobiological dose scaling introduces clinically relevant differences

多中心关于再放疗剂量累积的研究:不同中心间放射生物学剂量缩放引入临床上相关的差异

2026-05-190
OAAI
An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancer

一项国际多中心研究,旨在开发和验证基于联邦学习的肛癌预后模型

2026-03-140
OAAI
Clinical evidence and reporting standards in reirradiation: Insights from 28 studies at ESTRO 2025, endorsed by the ESTRO reirradiation focus group

再放疗的临床证据与报告标准:来自ESTRO 2025年会上28项研究的见解,并由ESTRO再放疗重点小组认可

2025-12-010
OAAI
Cumulative dose evaluation in clinical reirradiation – Consensus guidance on technical considerations by the ESTRO reirradiation focus group

临床再放疗中的累积剂量评估——ESTRO再放疗重点小组关于技术考量的共识指南

2025-11-270
OAAI
Predicting acute diarrhoea in rectal cancer chemoradiotherapy: Secondary analysis of the phase III ARISTOTLE trial

预测直肠癌化疗放疗中的急性腹泻:ARISTOTLE III期试验的二次分析

2025-07-050
PRE